Evaluation of Topical Tranexamic Acid with Tampon in Control of Anterior Nasal Epistaxis
Phase 3
Recruiting
- Conditions
- Epistaxis.EpistaxisR04.0
- Registration Number
- IRCT20191008045031N1
- Lead Sponsor
- Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
All Patients with Epistaxis under Treatment with Aspirin or Clopidogrel
Exclusion Criteria
Patients with a History of Thrombotic Disease
Pregnant Women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Stop of bleeding. Timepoint: Evaluation of Epistaxis Before Study and Until 24 Hours After the ?Study. Method of measurement: The Presence or ?Absence of Active Bleeding.;Relapse of Bleeding. Timepoint: Evaluation of Epistaxis Relapse After Three Days. Method of measurement: Active Bleeding After Stop of Bleeding.
- Secondary Outcome Measures
Name Time Method